Test your knowledge of prophylactic strategies in selected high-risk or outpatient CAR-T populations

Ciltacabtagene autoleucel has demonstrated high response rates in relapsed/refractory multiple myeloma but is associated with high rates of which toxicity?

Cytokine release syndrome

Hypothyroidism

Kidney stones

Alopecia

Which of the following can be administered prophylactically to mitigate the risk of cytokine release syndrome?

Fludarabine

Cyclophosphamide

Ruxolitinib

Tocilizumab

Which of the following is the hallmark symptom of cytokine release syndrome?

Pruritic urticarial rash

Fever

Bronchospasm with wheezing

Hyperglycemia

Which of the following are potential benefits of prophylactic tocilizumab?

Reduced risk of cytokine release syndrome

Reduced risk of hypotension or hypoxia

Increased rates of successful outpatient management

All of the above

{"name":"Test your knowledge of prophylactic strategies in selected high-risk or outpatient CAR-T populations", "url":"https://www.poll-maker.com/QWN959X6T","txt":"Ciltacabtagene autoleucel has demonstrated high response rates in relapsed\/refractory multiple myeloma but is associated with high rates of which toxicity?, Which of the following can be administered prophylactically to mitigate the risk of cytokine release syndrome?, Which of the following is the hallmark symptom of cytokine release syndrome?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}

Tools: Poll Maker | Quiz Maker